drugset / Trial / NCT01407263

Trial of Modifications to Radical Prostatectomy

NCT01407263

Phase 3 Active not recruiting 3204 enrolled Memorial Sloan Kettering Cancer Center
RandomizedFactorialOpen-labelTreatment

Summary

This trial will evaluate whether the following aspect of surgical technique influence outcome: Lymph node dissection. In some patients, scans taken before surgery show that a lymph node has cancer. Surgeons make sure to remove those affect lymph nodes and all other lymph nodes in the area. However, it is not known whether removing lymph nodes helps prostate cancer patients whose scans do not show positive nodes. In this study, patients with clear scans will either receive a lymph node dissection or not."

Timeline

Start
2011-07
Primary completion
2026-07
Completion
2026-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Arista Unknown
Subject CELLULOSE, OXIDIZED Other / unclassified
Subject Floseal Other / unclassified
Subject Surgicel SNoW Unknown

Indications